G01N 2800/325
Heart failure or cardiac arrest
Official title: Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
G01N2800/325 (Heart failure or cardiac arrest) appears on 320 US grants and 650 published applications in this corpus.
Search patents in G01N- Granted patents
- 320
- Published applications
- 650
- Assignees
- 312
- Inventors
- 1,050
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 4 |
| 2003 | 2 | 5 |
| 2004 | 1 | 14 |
| 2005 | 1 | 15 |
| 2006 | 2 | 17 |
| 2007 | 3 | 19 |
| 2008 | 6 | 21 |
| 2009 | 13 | 26 |
| 2010 | 9 | 47 |
| 2011 | 22 | 39 |
| 2012 | 15 | 45 |
| 2013 | 23 | 40 |
| 2014 | 15 | 34 |
| 2015 | 20 | 46 |
| 2016 | 17 | 35 |
| 2017 | 18 | 37 |
| 2018 | 19 | 28 |
| 2019 | 26 | 35 |
| 2020 | 16 | 27 |
| 2021 | 18 | 19 |
| 2022 | 12 | 21 |
| 2023 | 11 | 21 |
| 2024 | 9 | 21 |
| 2025 | 19 | 16 |
| 2026 | 14 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Galectin-3 immunoassay22 Sep 2026US 12,742,787 B2BG Medicine, Inc.
- Compositions and methods for treating heart failure18 Aug 2026US 12,708,658 B2Zensun (Shanghai) Science & Technology, Co., Ltd.
- Heart failure marker4 Aug 2026US 12,699,104 B2National University Corporation Kagawa University
- Diagnosis of stage B2 DMVD21 Jul 2026US 12,687,550 B2Boehringer Ingelheim Vetmedica GmbH
- Assessing and treating acute decompensated heart failure23 Jun 2026US 12,661,388 B2Mayo Foundation for Medical Education and Research
- Assessing and treating acute decompensated heart failure17 Sep 2026US 2026/0273021 A1Mayo Foundation for Medical Education and Research
- Methods of prognosis and treatment for heart failure with preserved ejection fraction using urinary protein levels3 Sep 2026US 2026/0259228 A1The Trustees of the University of Pennsylvania
- Methods of detecting a disease or condition27 Aug 2026US 2026/0251665 A1Biohabit Ltd
- Biomarker combinations for diagnosis of dilated cardiomyopathy and diagnostic kits therefor13 Aug 2026US 2026/0234726 A1
- Adamts12 as a target molecule for the treatment of chronic renal insufficiency and renal fibrosis16 Jul 2026US 2026/0202408 A1Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
Most cited
By later US patents
- Methods for early detection of heart disease231US 6,210,976 B1Medlyte Diagnostics, Inc. · 2001
- Kits for early detection of heart disease186US 6,534,322 B1Medlyte Diagnostics, Inc. · 2003
- Compositions and methods for early detection of heart disease184US 6,534,323 B1Medlyte Diagnostics, Inc. · 2003
- Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-193US 7,598,228 B2Asubio Pharma Co., Ltd. · 2009
- Cardiac muscle function and manipulation55US 7,226,907 B1Zensun (Shanghai) Science & Technology, Co., Ltd. · 2007